Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) shares rose 697.3% during mid-day trading on Monday . Get Mosaic ImmunoEngineering alerts:Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last released its quarterly earnings results on Wednesday, May 20th. Mosaic ImmunoEngineering Company ProfileMosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development. Recommended StoriesReceive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.